The genomic sequences of a portion of the 5' non-coding region of polioviruses excreted by recipients of the Sabin vaccine strains of poliovirus were examined. It was found that in all three types a residue changed in the course of excretion to give a sequence representing the consensus of poliovirus sequences. For type 1 this residue was at position 481, which altered in half the vaccinees, for type 2 it was at position 480, which altered in all vaccinees and for type 3 it was at position 472 in all vaccinees, as previously reported. Other vaccine strains unrelated to the Sabin strains but used in limited vaccination programmes did not have such changing residues. It was concluded that these regions indicated sequences that were strongly selected during replication in the human gut. Such sequences were further defined by examination of strains of poliovirus unrelated to the vaccine strains, the sequences of which may be expected to vary at less stringently defined regions.
strains, with a view to defining more closely the sequences required for optimal replication of polioviruses in the human gut. Faecal specimens were obtained from six children after primary vaccination in the U.K. with a mixture of all three serotypes of the Sabin vaccine strains at about 3 to 4 months of age. In addition isolates were obtained from one adult (Ju) and from two children (DM and EM) after the second vaccination. Finally type 3 isolates from an infant recipient of American vaccine, J, were kindly supplied by Dr M. Sulsinski of Lederle Laboratories. Viruses of a particular serotype were isolated on HEp-2c cells by plaque formation after treatment of the faecal suspension with monoclonal antibodies to neutralize the two unwanted serotypes as described by Minor et al. (1987) . Viruses were grown on HEp-2c cells, purified and the genomic RNA sequence determined .
The duration of excretion of the three serotypes in the vaccinees studied is shown in Table 1 . It can be seen that in general the type 2 component was the most successful in infecting recipients. Excretion of type 1 poliovirus was found in all vaccinees, although for a relatively short period. Excretion of the type 3 component, which occurred in five out of seven primary vaccinees and none of the secondary vaccinees, was prolonged where infection was established at all. These patterns of vaccine take are consistent with earlier studies (Henigst, 1966) .
The consensus sequence for the three Sabin vaccine strains for a region of 20 nucleotides corresponding to bases 471 to 491 of the genome according to the numbering of Toyoda et al. (1984) is shown in Fig. 1 . The sequence agrees with that published (Toyoda et al., 1984) . The type 1 sequence differs from the consensus at positions 477, 482 and 486, the type 2 sequence differs only at position 487, and the type 3 sequence at positions 475 and 483. In this numbering system which maximizes the alignment of the three sequences, position 475 corresponds to base 472 of the type 3 sequence, which we have shown to have an attenuating effect on the virus, and to revert rapidly to the consensus (C) in vaccinees excreting the type 3 strain (Evans et al., 1985) . Position 486 corresponds to base 480 of the type 1 sequence, which Omata et al. (1986) have shown has a major attenuating effect on the Sabin strain of type 1 poliovirus. Several strains of each serotype were isolated from each vaccinee at different times after vaccination. The region shown in Fig. 1 was examined to identify any mutating residues and to define the time of any change observed. It was found as previously reported (Evans et al., 1985) that all type 3 excreted strains reverted to the consensus sequence at base 475 of Fig. 1 , including isolates obtained from J, a primary vaccinee in the U.S.A. It was also found that all type 2 strains reverted to the consensus base G at position 487 of Fig. 1 , and that in four of the nine vaccinations examined, the type 1 strains reverted to the consensus base A at position 486 of Fig. 1 .
It was of interest that two of the three primary vaccinees in which the type 1 sequence reverted excreted virus for 26 days, a prolonged period compared to other vaccinees in whom reversion had not occurred. It was also noticeable that the type 1 strain from vaccinee DM reverted after both primary and secondary vaccination, but that from his sister, EM, failed to revert after either vaccination. The times at which reversion was demonstrated are expressed in Table 2 as days postvaccination. Type 1 isolates were obtained from DM after a second vaccination at days 4 and 8 only, and the day 4 isolate was Sabin strain-like. With this exception all reversions occurred within 1 week of vaccination, although there was variation between vaccinees. In particular, vaccinee J, an American child who received vaccine in the U.S.A., excreted a reverted type 3 strain at 3 days post-vaccination, comparable to the timing of the changes observed in the U.K. recipients.
All three strains of the Sabin poliovirus vaccines may thus revert to a consensus sequence at particular positions in the 5' non-coding region on replication in the human gut. In at least two cases the base that changes has been shown to be involved in the attenuation of the virus. It was thus possible that other candidate attenuated vaccine strains selected for lack of virulence in animals and used in early clinical trials might possess similar attenuating base changes in this region, which would revert in vaccine recipients. In this way regions necessary for replication in the human gut could be defined more precisely. Limited sequence data covering 100 bases from positions 451 to 551 in the numbering system of Toyoda et al. (1984) were obtained and are presented in Fig. 2 for three such strains. They were the two type 1 strains Cox and CHAT, which like the Sabin type 1 strain are derived from the Mahoney strain of type 1 poliovirus, and USOL-D-BAC, a type 3 strain unrelated to the Sabin type 3 strain. All three strains have been used as vaccines in the past. The sequence of Cox and CHAT from position 451 to position 551 is identical to that published for the parental Mahoney strain (Kitamura et al., 1981) . Thus no attenuating mutation was detected in this region. from that of Sabin type 3 at many positions in this 100 base sequence. However, virus excreted by four vaccine recipients in clinical trials was identical to the parental vaccine throughout this region (data not shown). It appears, therefore, that mutations in this region that affect replication in the human gut are found only in the Sabin vaccine strains. More extensive studies of the Cox and CHAT strains are under way. The sequence from positions 451 to 551 was determined for a limited number of wild-type strains to define completely conserved regions, where presumably a precise sequence was dictated by the requirements of the replication of the virus. The results are shown in Fig. 2 . The sequence from positions 451 to 475 was totally conserved in all strains examined except the Sabin type 3 vaccine strain, which has a U at position 475 incompatible with long term replication in the gut. Positions 476, 477, 478 and 482 were variable between types 1, 2 and 3. Position 483 differs from the consensus only in the Sabin type 3 strain, but this residue did not revert on replication of the virus in the gut of vaccine recipients. The residues at positions 479, 480, 481 and 484 to 488 were completely conserved except in the Sabin type 1 and 2 strains, which had residues at positions 486 and 487 respectively that were incompatible with prolonged replication in the human gut. Similar absolutely conserved sequences occur elsewhere in the sequence presented in Fig. 2 , for example from bases 539 to 550 and also elsewhere in the 5' noncoding region. Certain regions are conserved between poliovirus and other enteroviruses, such as coxsackieviruses B1, B3 and B4 (Iizuka et aI., 1987 ; Tracey et aL, 1985 ; Jenkins et al., 1987) and between poliovirus and rhinovirus 14 (Stanway et al., 1984) . It has been suggested that such sequences in the 5' and 3' non-coding regions may be involved in base-paired tertiary structures (Iizuka et al., 1987; Evans et al., 1985) . There is apparently a strong selection pressure to maintain a particular sequence in some of the limited regions described here, particularly at residues 475, 486 and 487 when the virus replicates in its natural habitat in the human gut. However, the effect of modification of such sequences on the biological properties of the virus is in general unknown. Over the region sequenced isolates P3/Fin/60212/85 and P3/Fin/25725/85 were identical. These isolates were obtained from the same individual 2 weeks apart, indicating that significant selection pressure to alter the sequence was not exerted over this period. The regions of variation from the consensus thus appear to be tolerated in a way in which the variations in the Sabin vaccine strains at residues 475, 486 and 487 are not.
It is striking that the Sabin vaccine strains of poliovirus all have unusual bases within a relatively short sequence in the 5' non-coding region. It is not clear why the Sabin strains have such mutations but other attenuated strains, selected for lack of virulence in the same animal model, do not. The bases at these positions rapidly revert to the consensus base on replication in the human gut. No in vitro cell culture system has yet been described which mimics this situation, implying that some factor in the environment inwhich the virus replicates in the gut is involved, either in the form of the cell in which the virus replicates, or the conditions in the relevant part of the gut. Identification of the relevant factor or an in vitro system having the same selective effect would make a major contribution to the elucidation of the functions of the 5' non-coding region of polioviruses.
